Impact of Duopa™ on Non-Motor Symptoms of Parkinson’s Patients with Deep Brain Stimulation
Objective: To report the role and impact of Duopa on non-motor Parkinsonian symptoms in patients with deep brain stimulation within a month from starting therapy.…Serum Mir-30c as a Potential Biomarker to Discriminate MSA from PD Patients: A Pilot Study.
Objective: In this pilot study we evaluated serum mir-30c levels in MSA and PD patients, to assess if mir-30c can be useful to distinguish these…Rare presentation of acute secondary parkinsonism in the post partum period.
Objective: To describe a rare presentation of acute secondary parkinsonism in the post partum period. Background: Background Posterior encephalopathy syndrome [PRES] is a rare complication…A Novel Model of Care for Advanced Parkinson’s Disease and Related Disorders: Interdisciplinary Home Visits
Objective: To describe the structure and feasibility of an interdisciplinary home visit program (HVP) for homebound advanced Parkinson’s disease (PD) and related disorders. Background: As…Safety and tolerability of deep brain stimulation in early stage Parkinson’s disease: Five-year follow-up of medication use and adverse events
Objective: To evaluate the long-term safety and tolerability of subthalamic nucleus deep brain stimulation (DBS) for early stage Parkinson’s disease (PD). Background: Twenty-nine subjects with…Weight Changes in STN and GPi Deep Brain Stimulation: Long Term Follow up
Objective: To determine the impact of deep brain stimulation (DBS) during long term follow-up of post-operative weight changes in Parkinson’s disease (PD). Background: PD patients…STN DBS can temporarily improve balance disorders in Parkinson’s disease (PD) patients.
Objective: The aim of this study was to evaluate the impact of STN DBS on balance disorders in PD patients. Background: Subthalamic nucleus deep brain…Genetic and Clinical Analysis of Cerebral Calcifications
Objective: Genetic and clinical analysis in primary cerebral calcification. Background: Cerebral calcification is associated with a variety of disorders of different aetiologies. To date, the primary…Is the GBA2 a new modifier for Gauchers’s disease and GBA1-related Parkinson’s disease?
Objective: This study was performed to determine the pathological role of GBA2 in the central nervous system(CNS) in Gaucher’s disease (GD) and GBA1-related Parkinson’s disease…Quantifying postural stability differences in people with Parkinson’s disease with and without freezing of gait, using body-worn sensors
Objective: To quantify differences in postural responses to perturbations in people with Parkinson disease (PD) with and without freezing of gait (FOG+, FOG-, resp.), using…
- « Previous Page
- 1
- …
- 281
- 282
- 283
- 284
- 285
- …
- 388
- Next Page »